Objective: To evaluate the clinical and electrophysiological determinants of arrhythmia recurrence in patients undergoing internal atrial cardioversion for chronic atrial fibrillation (AF). Setting: Tertiary cardiac referral centre. Methods: 101 consecutive patients with failed external cardioversion or AF greater than or equal to 1 year underwent internal atrial cardioversion; once stable sinus rhythm (SR) was obtained, electrophysiological study was performed in 73 patients (72%) who gave informed consent. Patients were then followed on antiarrhythmic treatment. Results: 101 consecutive patients underwent internal atrial cardioversion in the period 1996-1999 with 100% conversion to SR; prophylactic antiarrhythmic treatment was flecainide (52%), amiodarone (37%), and sotalol (11%). Average follow up at first AF recurrence was 18.4 (14.4) months (range 0.1-49.8 months); persistence of SR was observed in 72/101 (72%) patients. By logistic regression, AF duration (odds ratio (OR) 1.07, 95% confidence interval (0) 1.01 to 1.13) and a lower sinus rate at discharge on antiarrhythmic drugs (OR 0.92, 95% CI 0.85 to 0.99) were independent predictors of AF recurrence, whereas age, New York Heart Association functional class, left atrial dimensions, and left ventricular ejection fraction were not predictive of arrhythmia recurrence. When electrophysiological parameters were added to the statistical model in 73 patients, a shorter atrial effective refractoriness (OR I 04, 95% CI 1 to 1.08) and an abnormal relation of atrial effective refractoriness to cycle length (OR 31, 95% CI 3.7 to 266) were also independent predictors of AF recurrence at follow up, beyond AF duration and heart rate at discharge. Conclusions: Patients with failed external cardioversion or long lasting AF may benefit from internal atrial cardioversion and antiarrhythmic treatment to keep SR at long term; electrophysiological study may identify patients at the highest risk of arrhythmia recurrence, Although preservation of SR seems unlikely for AF duration > 3 years, a consistent minority of this subgroup (38%) may benefit from this approach.
|Data di pubblicazione:||2002|
|Titolo:||Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters|
|Autore/i:||Biffi, M; Boriani, Giuseppe; Bartolotti, M; Reggiani, Lb; Zannoli, R; Branzi, A.|
|Digital Object Identifier (DOI):||10.1136/heart.87.5.443|
|Codice identificativo ISI:||WOS:000175248500016|
|Codice identificativo Scopus:||2-s2.0-0036234179|
|Codice identificativo Pubmed:||11997417|
|Citazione:||Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters / Biffi, M; Boriani, Giuseppe; Bartolotti, M; Reggiani, Lb; Zannoli, R; Branzi, A.. - In: HEART. - ISSN 1355-6037. - 87:5(2002), pp. 443-448.|
|Tipologia||Articolo su rivista|
File in questo prodotto:
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris